GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according ...
Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...
Eli Lilly (LLY) said a study of its drug Ebglyss showed it was able to improve skin and itch in patients with atopic ...
The UK’s AstraZeneca, which is working on an oral GLP-1, also views the drugs as part of a combination strategy. In other ...
CNET on MSN8m
Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More ContextThe FDA recalled delayed-release capsules of duloxetine because they contain nitrosamines, which are everywhere but can be ...
ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep ...
Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets ...
A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around ...
New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...
Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of ...
Zacks.com on MSN4h
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to KnowEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback